According to the Huffington Post, scientists have recently zeroed in on a common feature in the brain receptors that play a role in pain, addiction, and memory loss.

Now in their latest study, Hamouda’s team was able to identify a structural difference in one type of receptor (the type that contributes to nicotine addiction, cognitive problems and pain), Hamouda said. That means such a drug might be effective in helping patients with all of these problems, he added. Though it’s important to note there is still a lot of work to do to design and develop the drug, and test it for all of these issues. An approved drug is still likely many years away.

Get the whole story at